Immunic, Inc. (IMUX)
NASDAQ: IMUX · IEX Real-Time Price · USD
1.410
+0.040 (2.92%)
At close: Jul 19, 2024, 4:00 PM
1.440
+0.030 (2.13%)
Pre-market: Jul 22, 2024, 6:08 AM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $127.01 million as of July 22, 2024. Its market cap has increased by 11.32% in one year.
Market Cap
127.01M
Enterprise Value
30.13M
1-Year Change
11.32%
Ranking
Category
Stock Price
$1.41
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $127.01M, a decrease of -49.88%. That is a compound annual growth rate of -6.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 127.00M | 87.59% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harvard Bioscience | 133.76M |
| Tevogen Bio Holdings | 133.36M |
| Veru Inc. | 132.29M |
| Compass Therapeutics | 128.89M |
| X4 Pharmaceuticals | 127.46M |
| Annovis Bio | 126.57M |
| Agenus | 125.79M |
| Relmada Therapeutics | 125.52M |